AATOD 2006 Conference Registration Brochure

More documents

Recommendations

Info

American Association for the Treatment of Opioid Dependence TREATING PEOPLE WITH DIGNITY: Pre-Conference Sessions Sunday, April 23, 2006 ➤ THE NATIONAL INSTITUTE ON DRUG ABUSE (NIDA) THE NATIONAL DRUG ABUSE TREATMENT CLINICAL TRIALS NETWORK (CTN) “Treating People with Dignity and Evidence Based Medicine: Emerging Research Findings on Buprenorphine, Hepatitis C and Prescription Drug Addiction” TIME: 8:30 AM – 5:00 PM 8:30 AM – 8:45 AM Registration and Continental Breakfast Session Chair: Betty Tai, PhD, Center for the Clinical Trials Network, National Institute on Drug Abuse, NIH, Bethesda, MD The Clinical Trials Network (CTN) is an important program of the National Institute on Drug Abuse (NIDA) focused on the design and implementation of clinically relevant studies in the field of drug addiction treatment research. It consists of 17 geographically diverse “Nodes” centered in key academic institutions, partnering with local Community Treatment Programs (CTPs). The objectives of the pre-conference session are: 1. Participants will learn how to use Buprenorphine in clinical settings including rapid detoxification, stabilization, and tapering from opioid addiction. 2. Participants will learn about the nature and extent of the problem of infectious diseases, especially Hepatitis C, and will learn innovative treatment approaches now being used in community treatment programs. 3. Participants will learn about using Buprenorphine and individual drug counseling to treat prescription opioid addicts including those with chronic pain. 4. Participants will learn about the availability of prescription drugs over the internet. AGENDA 8:45 AM Welcome & Introduction Betty Tai, PhD Director, Center for the Clinical Trials Network National Institute on Drug Abuse, NIH Bethesda, MD Buprenorphine: Pharmacotherapy for Addiction 9:00 AM Buprenorphine Opioid Detoxification Study Results: Treatment and Policy Implications Walter Ling, MD Principal Investigator, Pacific Region Node, NIDA CTN Director, Integrated Substance Abuse Programs, Los Angeles, CA Professor of Psychiatry and Biobehavioral Sciences, UCLA Los Angeles, CA 9:40 AM Buprenorphine Treatment in Pregnant Women Hendree Jones, PhD Associate Professor, Department of Psychiatry, JHU Research Director, Center for Addiction & Pregnancy Baltimore, MD 10:20 AM Dissemination: Buprenorphine Awareness Package Thomas Freese, PhD Director, Pacific Southwest Addiction Technology Transfer Center (ATTC) Los Angeles, CA 11:00 AM Buprenorphine in the Community Setting Allan J. Cohen, MA Director of Research and Training Bay Area Addiction Research and Treatment, Inc. Los Angeles, CA 11:30 AM Lunch National Conference Atlanta 2006 6
Working with Criminal Justice and Health Care Systems American Association for the Treatment of Opioid Dependence Pre-Conference Sessions Sunday, April 23, 2006 (continued) Infectious Diseases: HCV Comorbidity 12:30 PM HCV Infection: A Scientific View David Thomas, MD Associate Professor, Division of Infectious Diseases Johns Hopkins University School of Medicine Baltimore, MD 1:10 PM Policies: HCV Services in Substance Abuse Treatment Lawrence Brown, MD Senior Vice President, Addiction Research & Treatment Corporation Clinical Associate Professor of Public Health, Weill Medical College, Cornell University Immediate Past President, American Society of Addiction Medicine Brooklyn, NY 1:50 PM HCV Education: Improving Treatment Diana Sylvestre, MD Assistant Clinical Professor, Department of Medicine, University of California-San Francisco Oakland, CA 2:30 PM The Community Perspective Paul McLaughlin, MA Director, Hartford Dispensary Hartford, CT 3:00 PM Break Prescription Drugs: Abuse and Addiction 3:20 PM The Availability of Controlled Substances Over the Internet Robert F. Forman, PhD Co-Principal Investigator, Delaware Valley Node, NIDA CTN Assistant Professor, Department of Psychiatry, University of Pennsylvania, Treatment Research Center Senior Investigator, Treatment Research Institute Philadelphia, PA 4:00 PM POATS: Treating Prescription Opioid Addiction Jennifer Sharpe Potter, PhD Research Director, Northern New England Node, NIDA CTN Instructor in Psychology, Department of Psychiatry, Harvard Medical School Belmont, MA 4:30 PM Discussion Petra Jacobs, MD Medical Officer, Center for Clinical Trials Network National Institute on Drug Abuse, NIH Bethesda, MD 5:00 PM Adjourn Sponsored by The National Institute on Drug Abuse, The National Drug Abuse Treatment Clinical Trials Network (NIDA CTN). National Conference Atlanta 2006 7
Page 1 and 2: American Association for the Treatm
Page 3 and 4: Working with Criminal Justice and H
Page 7: Working with Criminal Justice and H
Page 27 and 28: Registration Form American Associat

AATOD 2006 Conference Registration Brochure

Create successful ePaper yourself

Delete template?

Save as template?